Take a look at Teva Pharmaceuticals...if you want to know where generic pharma's are heading. Profit margins are squeezed down to nothing with generic sales, thanks to indian/chinese manufacturing. The time we did have Apicore ownership, revenues were anemic. Friessen did the right thing, got out when there was a buyer.